Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan
- Status
- COMPLETED
- Phase
- PHASE2
Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches
- Status
- COMPLETED
- Phase
- PHASE2
Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra
- Status
- COMPLETED
- Phase
- PHASE1
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Asunaprevir/Daclatasvir Safety Surveillance in Japanese Patients With Chronic Hepatitis C
- Status
- COMPLETED
- Phase
- N/A
BMS-986012 in Relapsed/Refractory SCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
- Status
- COMPLETED
- Phase
- PHASE3